Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Jachs

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Alimentary Pharmacology & Therapeutics|September 21, 2024
Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortalityLukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Alimentary Pharmacology & Therapeutics|November 4, 2024
Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' ReplyLukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Infectious Diseases (London, England)|December 9, 2022
Progress of Hepatitis C elimination in Viennese people living with HIV after two decades of increasing cure ratesDavid Chromy, David Bauer, Benedikt Simbrunner, et al.
Wiener Klinische Wochenschrift|November 12, 2022
The impact of COVID-19 on liver transplantation programs in AustriaLukas Hartl, Elisabeth Tatscher, Melanie Weiss, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2022
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation eventLorenz Balcar, Marta Tonon, Georg Semmler, et al.
United European Gastroenterology Journal|November 25, 2025
Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver-Related DeathCaroline Schwarz, Andrea Kornfehl, Reema Abid, et al.
Gut|November 17, 2020
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomesMathias Jachs, Lukas Hartl, Dunja Schaufler, et al.
JHEP Reports : Innovation in Hepatology|September 30, 2022
Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver diseaseLorenz Balcar, Bernhard Scheiner, Markus Urheu, et al.
European Radiology|September 27, 2022
Imaging features facilitate diagnosis of porto-sinusoidal vascular disorderKatharina Lampichler, Georg Semmler, Katharina Wöran, et al.
Annals of Hepatology|November 28, 2025
Pancreatic involvement and its prognostic impact in acute-on-chronic liver failureGeorg Kramer, Vlad Taru, Benedikt Simbrunner, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Alimentary Pharmacology & Therapeutics|September 21, 2024
Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortalityLukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Alimentary Pharmacology & Therapeutics|November 4, 2024
Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' ReplyLukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Infectious Diseases (London, England)|December 9, 2022
Progress of Hepatitis C elimination in Viennese people living with HIV after two decades of increasing cure ratesDavid Chromy, David Bauer, Benedikt Simbrunner, et al.
Wiener Klinische Wochenschrift|November 12, 2022
The impact of COVID-19 on liver transplantation programs in AustriaLukas Hartl, Elisabeth Tatscher, Melanie Weiss, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2022
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation eventLorenz Balcar, Marta Tonon, Georg Semmler, et al.
United European Gastroenterology Journal|November 25, 2025
Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver-Related DeathCaroline Schwarz, Andrea Kornfehl, Reema Abid, et al.
Gut|November 17, 2020
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomesMathias Jachs, Lukas Hartl, Dunja Schaufler, et al.
JHEP Reports : Innovation in Hepatology|September 30, 2022
Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver diseaseLorenz Balcar, Bernhard Scheiner, Markus Urheu, et al.
European Radiology|September 27, 2022
Imaging features facilitate diagnosis of porto-sinusoidal vascular disorderKatharina Lampichler, Georg Semmler, Katharina Wöran, et al.
Annals of Hepatology|November 28, 2025
Pancreatic involvement and its prognostic impact in acute-on-chronic liver failureGeorg Kramer, Vlad Taru, Benedikt Simbrunner, et al.
Pageof 12